# EDGAR Filing Document

**Accession Number:** 0001686315
**File Stem:** 0001493152-25-028145
**Filing Date:** 2025-12
**Character Count:** 10634
**Document Hash:** 50492b7e18ae00fb541aa0b2e5be2a07
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-028145.hdr.sgml**: 20251217

**ACCESSION NUMBER**: 0001493152-25-028145

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251217

**DATE AS OF CHANGE**: 20251217

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** My Size, Inc.
- **CENTRAL INDEX KEY:** 0001211805
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90920
- **FILM NUMBER:** 251579455

**BUSINESS ADDRESS:**
- **STREET 1:** 4 HANEGEV ST,
- **STREET 2:** POB 1026,
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000
- **BUSINESS PHONE:** 972-36009030

**MAIL ADDRESS:**
- **STREET 1:** 4 HANEGEV ST,
- **STREET 2:** POB 1026,
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mysize Inc.
- **DATE OF NAME CHANGE:** 20150317

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TOPSPIN MEDICAL INC
- **DATE OF NAME CHANGE:** 20021226
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Luzon Ronen
- **CENTRAL INDEX KEY:** 0001686315

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 3 ARAVA ST. P.O.B 1026
- **CITY:** AIRPORT CITY
- **PROVINCE COUNTRY:** L3

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**My Size, Inc.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**62844N406**

*(CUSIP Number)*

**Ronen Luzon**<br>c/o My Size, Inc. HaNegev 4<br>POB 1026<br>Airport City L3 7019900<br>972-54-4775656

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/15/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **62844N406** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Ronen Luzon** | Name of reporting person<br>**Ronen Luzon** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**L3** | Citizenship or place of organization<br>**L3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**289335.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**369085.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**289335.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**369085.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**369085.00** | Aggregate amount beneficially owned by each reporting person<br>**369085.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**8.02%** | Percent of class represented by amount in Row (11)<br>**8.02%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** Items 8, 10 and 11 Consist of (i) 289,335 shares of restricted stock, and (ii) 79,750 shares of restricted stock which are held by the Reporting Person's spouse. Item 13 is based upon 4,599,784 shares of common stock outstanding on December 15, 2025 which amount was provided to the Reporting Person by the Issuer and assumes the issuance of restricted stock awards granted on December 15, 2025.

| **CUSIP No.** | **62844N406** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Billy Pardo** | Name of reporting person<br>**Billy Pardo** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**L3** | Citizenship or place of organization<br>**L3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**79750.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**369085.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**79750.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**369085.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**369085.00** | Aggregate amount beneficially owned by each reporting person<br>**369085.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**8.02%** | Percent of class represented by amount in Row (11)<br>**8.02%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** Items 8, 10 and 11 Consist of (i) 79,750 shares of restricted stock, and (ii) 289,335 shares of restricted stock which are held by the Reporting Person's spouse. Item 13 is based upon 4,599,784 shares of common stock outstanding on December 15, 2025 which amount was provided to the Reporting Person by the Issuer and assumes the issuance of restricted stock awards granted on December 15, 2025.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
My Size, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
HaNegev 4, POB 1026, Airport City, L3, 7019900

On April 19, 2024, the Issuer implemented a 1-for-8 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.

**Item 4. Purpose of Transaction**

Item 3 above is hereby incorporated into this Item 4 by reference. Each Reporting Person serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

As of the date hereof, each Reporting Person in their individual capacities does not have any present plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of Item 4 to Schedule 13D. Each Reporting Person may, at any time and from time to time, (i) review or reconsider his or her position in the Issuer or change his or her purpose or formulate plans or proposals with respect thereto or (ii) propose or consider one or more of the actions described in clauses (a) through (j) of Item 4 to Schedule 13D.

From time to time, each Reporting Person may also acquire beneficial ownership of additional Shares or other securities of the Issuer as compensation from the Issuer, by purchase or otherwise, including, including, but not limited to, awards of restricted Shares, options to purchase Shares, and restricted stock units for Shares, or dispose of some or all of the Shares beneficially owned by such Reporting Person in the open market or in privately negotiated transactions (which may be with the Issuer or with third parties) on such terms and at such times as such Reporting Person may deem advisable.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the text in the comments box thereto) is incorporated by reference herein.

**(b)**
The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the text in the comments box thereto) is incorporated by reference herein.

**(c)**
No transactions in the Issuer's Shares were effected during the past 60 days by the Reporting Person except as set forth in Item 3 above.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit A to the Schedule 13D filed by the Reporting Persons with the SEC on November 21, 2022, pursuant to which the Reporting Persons agreed to file such Schedule 13D and any amendments thereto jointly in accordance with the provisions of Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, as amended.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Ronen Luzon

**Signature:** /s/ Ronen Luzon

**Name/Title:** Chief Executive Officer

**Date:** 12/17/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Billy Pardo

**Signature:** /s/ Billy Pardo

**Name/Title:** Chief Product Officer and Chief Operating Officer

**Date:** 12/17/2025